A phase I study of BI 811283, an Aurora B kinase inhibitor, in patients with advanced solid tumors

by Mross, Klaus, Richly, Heike, Frost, Annette, Scharr, Dirk, Nokay, Bahar, Graeser, Ralph, Lee, Chooi, Hilbert, James, Goeldner, Rainer-George, Fietz, Oliver, Scheulen, Max E.
Published 2016